Erratum to: Keratinocyte growth factor in acute lung injury to reduce pulmonary dysfunction – a randomised placebo-controlled trial (KARE): study protocol

by Laurence J. M. Cross, Cecilia M. O’Kane, Cliona McDowell, Jospeh J. Elborn, Michael A. Matthay, Daniel F. McAuley
Published 2017-05-01

A Porcine Ex Vivo Lung Perfusion Model To Investigate Bacterial Pathogenesis

by Amy Dumigan, Marianne Fitzgerald, Joana Sá-Pessoa Graca Santos, Umar Hamid, Cecilia M. O’Kane, Danny F. McAuley, Jose A. Bengoechea
Published 2019-12-01

Hyperoxaemia and hypoxaemia are associated with harm in patients with ARDS

by Andrew J. Boyle, David N. Holmes, Jonathan Hackett, Susanna Gilliland, Michael McCloskey, Cecilia M. O’Kane, Paul Young, Stefania Di Gangi, Daniel F. McAuley
Published 2021-09-01

Identifying associations between diabetes and acute respiratory distress syndrome in patients with acute hypoxemic respiratory failure: an analysis of the LUNG SAFE database

by Andrew J. Boyle, Fabiana Madotto, John G. Laffey, Giacomo Bellani, Tài Pham, Antonio Pesenti, B. Taylor Thompson, Cecilia M. O’Kane, Adam M. Deane, Daniel F. McAuley, on behalf of the LUNG SAFE Investigators, the ESICM Trials Group
Published 2018-10-01

Simvastatin to reduce pulmonary dysfunction in patients with acute respiratory distress syndrome: the HARP-2 RCT

by Daniel F McAuley, John G Laffey, Cecilia M O’Kane, Gavin D Perkins, Brian Mullan, Thomas J Trinder, Paul Johnston, Phillip A Hopkins, Andrew J Johnston, Lynn Murphy, Christine McNally, Ashley M Agus, Clíona McDowell, Colette Jackson
Published 2018-01-01

Defining phenotypes and treatment effect heterogeneity to inform acute respiratory distress syndrome and sepsis trials: secondary analyses of three RCTs

by Manu Shankar-Hari, Shalini Santhakumaran, A Toby Prevost, Josie K Ward, Timothy Marshall, Claire Bradley, Carolyn S Calfee, Kevin L Delucchi, Pratik Sinha, Michael A Matthay, Jonathan Hackett, Cliona McDowell, John G Laffey, Anthony Gordon, Cecilia M O’Kane, Daniel F McAuley
Published 2021-07-01